AssetID: 54012867
Headline: New Bone-Strengthening Drug Abaloparatide Approved for Post-Menopausal Women by NHS
Caption: Tens of thousands of post-menopausal women could benefit from Abaloparatide, a new bone-strengthening drug approved by NICE for NHS use in England, BBC News reports. Abaloparatide can protect against osteoporosis, a bone-thinning condition that increases the risk of fractures in older women.
Keywords: New,Bone,Strengthening,Drug,Abaloparatide,Approved,Post-Menopausal,Women,NHS,Health,Lifestyle,Wellbeing,Fitness,Bones,Older,Elderly,Conditions,Risk,Fractures
PersonInImage: